Morse Asset Management, Inc Zoetis Inc. Transaction History

Morse Asset Management, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$151.44 - $200.09 $1.1 Million - $1.46 Million	-7,274 Reduced 63.4%	4,200 $829,000
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $462,309 - $533,201	-2,766 Reduced 19.42%	11,474 $2 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $2.29 Million - $2.65 Million	14,240 New	14,240 $2.45 Million
Q4 2020 Feb 11, 2021	SELL	$157.07 - $174.35 $357,334 - $396,646	-2,275 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$137.1 - $165.37 $311,902 - $376,216	2,275 New	2,275 $376,000
Q4 2019 Jan 31, 2020	SELL	$116.25 - $133.25 $787,012 - $902,102	-6,770 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$112.57 - $128.43 $53,470 - $61,004	-475 Reduced 6.56%	6,770 $843,000
Q2 2019 Aug 01, 2019	BUY	$97.98 - $114.28 $709,865 - $827,958	7,245 New	7,245 $822,000
Q1 2019 May 02, 2019	SELL	$81.56 - $100.67 $2.5 Million - $3.08 Million	-30,625 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$79.28 - $95.27 $517,302 - $621,636	6,525 Added 27.07%	30,625 $2.62 Million
Q3 2018 Nov 01, 2018	BUY	$83.5 - $93.23 $1.29 Million - $1.44 Million	15,450 Added 178.61%	24,100 $2.21 Million
Q2 2018 Aug 15, 2018	BUY	$79.9 - $89.2 $691,135 - $771,580	8,650 New	8,650 $737,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.